Patent: 9,051,617
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 9,051,617
Title: | Markers for breast cancer |
Abstract: | Correlations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators are also described. |
Inventor(s): | Cox; David (Belmont, CA), Ballinger; Dennis (Menlo Park, CA), Ponder; Bruce (Cambridge, GB), Easton; Doug (Welwyn, GB) |
Assignee: | Cambridge Enterprise Limited (Cambridge, GB) |
Application Number: | 12/890,272 |
Patent Claims: | see list of patent claims |
Details for Patent 9,051,617
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | See Plans and Pricing | 2025-11-29 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | See Plans and Pricing | 2025-11-29 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | See Plans and Pricing | 2025-11-29 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |